Across TCGA pan-cancer cohorts, RNU6-1235P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU6-1235P data layer.

The strongest signal is observed in pheochromocytoma and paraganglioma (PCPG), where higher RNU6-1235P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1235P expression acts as an unfavorable survival marker.

PCPG and SKCM are the cancer types where RNU6-1235P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PCPG	OS	Tertile	All	0.516	0.948	.002	36	view →
SKCM	DFS	Tertile	III,IV	0.129	0.601	.002	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNU6-1235P tumor-vs-normal RNA expression · all RNU6-1235P data types